IOV - Instituto Oncologico Veneto IRCCS

Site:	IOV - Instituto Oncologico Veneto IRCCS
Address:
City:	Padova
State:
Zip:
Country:	Italy

Phase	Trial	Trial Status	Site Status [asc]	Drug	NCT#
3	A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib (intrigue)	Active, not recruiting	Active	QINLOCK Ripretinib DCC-2618 SUTENT Sunitinib	NCT03673501
3	A Phase 3 Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib (INSIGHT)	Recruiting	Active	Ripretinib	NCT05734105